Genus plc
GNS
Rank in Stocks
#5765
Genus plc is a global animal genetics company with operations spanning North... Genus plc is a global animal genetics company with operations spanning North America, Latin America, the UK, continental Europe, the Middle East, Russia, Africa, and Asia. The business is divided into three key segments: Genus PIC, Genus ABS, and Genus Research and Development. Under its PIC brand, the company provides breeding stock, including sows, boars, and semen, to develop pigs with specific characteristics optimized for pork production. Similarly, for cattle, its ABS, Genus, and Bovec brands offer bull semen and embryos designed to produce calves with advantageous traits for either milk or beef output. Farmers also benefit from a range of specialized technical services, such as semen sexing and reproductive solutions. Genus plc is also strategically collaborating with Beijing Capital Agribusiness Co. Ltd on the research, development, and regulatory approval of porcine reproductive and respiratory syndrome virus (PRRSV)-resistant pigs in China. The company was established in 1994 and is based in Basingstoke, United Kingdom.
Share Price
$32.39
Last synced: 2026-11-09
Market Cap
$2.09B
Change (1 day)
1.35%
Change (1 year)
3.27%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Genus plc (GNS)
Category
Healthcare
Operating Margin for Genus plc (GNS)
Operating Margin as of November 2026 TTM: 13.27%
According to Genus plc's latest financial reports, its current operating margin (TTM) is 13.27%. At the end of 2025 the company had an operating margin of 6.30%.
Operating Margin history for Genus plc from 2001 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 13.27% | 110.63% |
| 2025 | 6.30% | 556.25% |
| 2024 | 0.96% | -83.65% |
| 2023 | 5.87% | -38.47% |
| 2022 | 9.54% | -10.92% |
| 2021 | 10.71% | 30.13% |
| 2020 | 8.23% | -9.26% |
| 2019 | 9.07% | 2.02% |
| 2018 | 8.89% | 0.57% |
| 2017 | 8.84% | -7.72% |
| 2016 | 9.58% | -175.02% |
| 2015 | -12.77% | -18.87% |
| 2014 | -15.74% | -260.29% |
| 2013 | 9.82% | -38.08% |
| 2012 | 15.86% | 9.68% |
| 2011 | 14.46% | -12.20% |
| 2010 | 16.47% | 39.93% |
| 2009 | 11.77% | 11.04% |
| 2008 | 10.60% | -12.76% |
| 2007 | 12.15% | 21.62% |
| 2006 | 9.99% | 28.57% |
| 2005 | 7.77% | 63.24% |
| 2004 | 4.76% | -19.32% |
| 2003 | 5.90% | 26.34% |
| 2002 | 4.67% | 19.13% |
| 2001 | 3.92% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -97.09% |
US
|
|
| -149.01% | -111.23% |
US
|
|
| 25.57% | -98.07% |
AU
|
|
| 31.23% | -97.65% |
BE
|
|
| 29.35% | -97.79% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Genus plc's operating margin
What is Genus plc's operating margin?
Genus plc's operating margin is 13.27%, as of Nov 2026.
What was Genus plc's operating margin in 2025?
In 2025, Genus plc's operating margin was 6.30%, compared with 0.96% in 2024.
How has Genus plc's operating margin changed since 2020?
From 2020 to 2025, Genus plc's operating margin was highest in 2021 (10.71%) and lowest in 2024 (0.96%).
How does Genus plc's operating margin compare with similar companies?
Genus plc's operating margin (13.27%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.